Pay in 4 interest-free payments of $6.40 Learn more
Ships within 48 hours · Estimated delivery Sep 3 - Sep 8
Controlled human research evaluating the combination remains limited
GHK-Cu ma dodatkowo przyczon czsteczk miedzi, do ktrej ma silne powinowactwo, dziki czemu zwiksza aktywno dysmutazy ponadtlenkowej, czyli naszej najsilniejszej tarczy antyoksydacyjnej
Initially conceptualized as a therapeutic for neurodegenerative disorders such as Alzheimers and Parkinsons disease, its primary mechanism of action involves high-affinity binding to hepatocyte growth factor (HGF) and its cognate receptor c-Met
Because it raises GH, blood sugar can rise and IGF-1 should be monitored
Leqvio +114% cc Key Peptide Products: Lutathera (lutetium-177 DOTATATE, oncology peptide receptor radionuclide), Pluvicto (177Lu-PSMA-617), Sandostatin/Signifor (octreotide/pasireotide somatostatin analogues), Leqvio (inclisiran siRNA, category-adjacent) Therapeutic Segments: Oncology (radioligand therapy, CDK4/6 inhibitors)
